Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
Abstract Background Co-administration of letrozole during the first 5 days of ovarian stimulation was suggested to improve IVF outcomes in poor responders. We aimed to determine whether poor/sub-optimal responders might benefit from Letrozole co-treatment throughout the entire stimulation course. Me...
Saved in:
Main Authors: | Moran Shapira (Author), Raoul Orvieto (Author), Oshrit Lebovitz (Author), Ravit Nahum (Author), Adva Aizer (Author), Aliza Segev-Zahav (Author), Jigal Haas (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting IVF outcome in poor ovarian responders
by: Oshrit Lebovitz, et al.
Published: (2022) -
Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
by: Raoul Orvieto, et al.
Published: (2021) -
Determining the optimal daily gonadotropin dose to maximize the oocyte yield in elective egg freezing cycles
by: Raoul Orvieto, et al.
Published: (2024) -
Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU
by: Raoul Orvieto, et al.
Published: (2022) -
Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
by: Jigal Haas, et al.
Published: (2017)